Universal Ibogaine Inc.

IBOGF · OTC
Analyze with AI
4/30/2025
1/31/2025
4/30/2023
1/31/2023
Operating Activities
Net Income-$66-$304-$487-$793
Dep. & Amort.$80$89$72$69
Deferred Tax$0$0$0$210
Stock-Based Comp.$0$0$26-$3
Change in WC-$130$11$199$8
Other Non-Cash$5$3$17$27
Operating Cash Flow-$110-$202-$172-$481
Investing Activities
PP&E Inv.$0$0-$43-$211
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$43-$211
Financing Activities
Debt Repay.-$32-$32$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$4$416$380$182
Financing Cash Flow-$36$384$376$180
Forex Effect$0$0$0$0
Net Chg. in Cash-$146$182$161-$512
Supplemental Information
Beg. Cash$274$92$192$704
End Cash$128$274$353$192
Free Cash Flow-$110-$202-$215-$691
Universal Ibogaine Inc. (IBOGF) Financial Statements & Key Stats | AlphaPilot